• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用通过人工授精培育的缺乏凝血因子VII的比格犬来评估与凝血酶原复合物浓缩物相关的血栓形成机制。

Use of factor VII-deficient beagles bred by artificial insemination to evaluate mechanisms of thrombosis associated with prothrombin complex concentrates.

作者信息

Ferguson J M, MacGregor I R, McLaughlin L F, Prowse C V

机构信息

Wellcome Surgical Institute, University of Glasgow.

出版信息

Blood Coagul Fibrinolysis. 1991 Dec;2(6):731-4. doi: 10.1097/00001721-199112000-00006.

DOI:10.1097/00001721-199112000-00006
PMID:1799659
Abstract

Artificial insemination with frozen semen was used to breed beagles homozygous for a deficiency in clotting factor VII, with plasma concentrations of 2-3% of normal adult beagle pooled plasma. The factor VII-deficient beagles were used to determine if factor VII activity has a role in the thrombogenic activity of prothrombin complex concentrates (PCCs) containing factors II, IX and X by evaluating changes in selected indicators of thrombogenicity. No differences were seen between the responsiveness of the factor VII-deficient and normal beagles, indicating that the thrombogenic activities of PCCs are mediated via effects on the intrinsic clotting system.

摘要

采用冷冻精液人工授精的方法繁育了凝血因子 VII 缺乏的纯合比格犬,其血浆浓度为正常成年比格犬混合血浆的 2%-3%。通过评估血栓形成性的选定指标变化,利用这些凝血因子 VII 缺乏的比格犬来确定因子 VII 活性在含有因子 II、IX 和 X 的凝血酶原复合物浓缩物(PCCs)的血栓形成活性中是否起作用。凝血因子 VII 缺乏的比格犬和正常比格犬的反应性未见差异,这表明 PCCs 的血栓形成活性是通过对内源性凝血系统的作用介导的。

相似文献

1
Use of factor VII-deficient beagles bred by artificial insemination to evaluate mechanisms of thrombosis associated with prothrombin complex concentrates.使用通过人工授精培育的缺乏凝血因子VII的比格犬来评估与凝血酶原复合物浓缩物相关的血栓形成机制。
Blood Coagul Fibrinolysis. 1991 Dec;2(6):731-4. doi: 10.1097/00001721-199112000-00006.
2
In vivo models of thrombogenic potential: usefulness and limitations.血栓形成潜力的体内模型:用途与局限性。
Acta Haematol. 1995;94 Suppl 1:18-23; discussion 24. doi: 10.1159/000204039.
3
The influence of residual factor VII on the sensitivity of brain thromboplastin.残余因子VII对脑凝血活酶敏感性的影响。
Thromb Haemost. 1978 Jun 30;39(3):592-9.
4
Influence of prothrombin complex concentrates on plasma coagulation in critically ill patients.凝血酶原复合物浓缩剂对危重症患者血浆凝血的影响。
Intensive Care Med. 1999 Oct;25(10):1105-10. doi: 10.1007/s001340051019.
5
Comparison of high purity factor IX concentrates and a prothrombin complex concentrate in a canine model of thrombogenicity.在犬血栓形成模型中高纯度凝血因子IX浓缩物与凝血酶原复合物浓缩物的比较。
Thromb Haemost. 1991 Nov 1;66(5):609-13.
6
Thrombogenicity of a factor IX concentrate quantitated in a canine model.在犬类模型中定量测定的凝血因子IX浓缩剂的血栓形成性。
Blood Coagul Fibrinolysis. 1990 Mar-Apr;1(1):23-30. doi: 10.1097/00001721-199003000-00005.
7
Human coagulation factor IX: assessment of thrombogenicity in animal models and viral safety.人凝血因子IX:动物模型中血栓形成性评估及病毒安全性评估
J Lab Clin Med. 1993 Mar;121(3):394-405.
8
A novel rat model of thrombogenicity: its use in evaluation of prothrombin complex concentrates and high purity factor IX concentrates.
Thromb Haemost. 1992 Nov 10;68(5):511-5.
9
A comparison of the in vitro and in vivo thrombogenic activity of factor IX concentrates using stasis (Wessler) and non-stasis rabbit models.
Thromb Haemost. 1980 Oct 31;44(2):81-6.
10
Prothrombin complex concentrates: clinical use.凝血酶原复合物浓缩剂:临床应用
Ann N Y Acad Sci. 1981;370:747-56. doi: 10.1111/j.1749-6632.1981.tb29782.x.